Fortis Inc/ CA3495531079 /
| 2024-07-16 10:10:00 PM | Chg. +0.31 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 39.82USD | +0.78% | 334,404 Turnover: 10.23 mill. |
38.69Bid Size: 100 | 41.02Ask Size: 100 | 19.53 bill.USD | - | - |
GlobeNewswire
06-18
FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program ...
GlobeNewswire
06-10
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annu...
GlobeNewswire
05-23
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
05-15
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
04-24
Advisory: Fortis Inc. to Hold Teleconference on May 1 to Discuss First Quarter 2024 Results and Hold...
GlobeNewswire
04-24
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combinat...
GlobeNewswire
04-23
Maryland CareerQuest Connects Area Students with Training and Education Opportunities for Hands-On C...
GlobeNewswire
04-03
Fortis Inc. to Hold Teleconference on May 1 to Discuss First Quarter 2024 Results and Hold Annual an...
GlobeNewswire
04-02
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metast...
GlobeNewswire
03-28
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial ...
GlobeNewswire
03-19
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning
GlobeNewswire
03-13
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
03-01
Sage Transform 2024 Unveils Sage Copilot and Introduces Groundbreaking Tech Innovations, Product Enh...
GlobeNewswire
03-01
Sage Transform 2024 Unveils Sage Copilot and Introduces Groundbreaking Tech Innovations, Product Enh...
